- Home
- ORBS vs INMB Comparison
ORBS vs INMB Comparison
Compare ORBS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORBS
- INMB
- Stock Information
- Founded
- ORBS 1966
- INMB 2015
- Country
- ORBS United States
- INMB United States
- Employees
- ORBS N/A
- INMB N/A
- Industry
- ORBS
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- ORBS
- INMB Health Care
- Exchange
- ORBS Nasdaq
- INMB Nasdaq
- Market Cap
- ORBS 47.6M
- INMB 49.2M
- IPO Year
- ORBS N/A
- INMB 2019
- Fundamental
- Price
- ORBS $5.47
- INMB $1.87
- Analyst Decision
- ORBS
- INMB Hold
- Analyst Count
- ORBS 0
- INMB 3
- Target Price
- ORBS N/A
- INMB $4.30
- AVG Volume (30 Days)
- ORBS 4.6M
- INMB 349.2K
- Earning Date
- ORBS 11-13-2025
- INMB 10-30-2025
- Dividend Yield
- ORBS N/A
- INMB N/A
- EPS Growth
- ORBS N/A
- INMB N/A
- EPS
- ORBS N/A
- INMB N/A
- Revenue
- ORBS $43,871,615.00
- INMB $50,000.00
- Revenue This Year
- ORBS N/A
- INMB $264.29
- Revenue Next Year
- ORBS N/A
- INMB $9,819.61
- P/E Ratio
- ORBS N/A
- INMB N/A
- Revenue Growth
- ORBS N/A
- INMB N/A
- 52 Week Low
- ORBS $0.98
- INMB $1.71
- 52 Week High
- ORBS $83.12
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- ORBS N/A
- INMB 45.15
- Support Level
- ORBS N/A
- INMB $1.79
- Resistance Level
- ORBS N/A
- INMB $1.95
- Average True Range (ATR)
- ORBS 0.00
- INMB 0.10
- MACD
- ORBS 0.00
- INMB 0.01
- Stochastic Oscillator
- ORBS 0.00
- INMB 46.00
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.